Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal.

histological template lung allograft lung transplantation pathology transbronchial biopsies

Journal

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
ISSN: 1557-3117
Titre abrégé: J Heart Lung Transplant
Pays: United States
ID NLM: 9102703

Informations de publication

Date de publication:
10 2022
Historique:
received: 10 01 2022
revised: 10 06 2022
accepted: 24 06 2022
pubmed: 6 8 2022
medline: 5 10 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

Routine monitoring of lung-transplanted patients is crucial for the identification of immunological and non-immunological complications. Determining the etiology of acute allograft dysfunction, particularly in alloimmune-mediated disorders, relies heavily on the lung biopsy with histopathologic analysis. Standardization of the pathologic diagnosis of rejection (e.g., cellular and antibody-mediated) is based on consensus statements and guidelines, indicating the importance of a multidisciplinary approach to achieve a definitive etiological diagnosis. In addition to these statements and guidelines, refinements and standardizations are feasible through systematic analysis morphological, immunophenotypic and molecular alterations observed in transbronchial biopsies. This study is to identify key morphologic features to be assessed, select consistent and reproducible terminology for each histological feature, and provide standardized definitions for pathological assessment and grading. A template was created by experts in lung transplantation including pathologists, pulmonologists, immunologists. An initial draft was circulated, followed by discussions and multiple revisions by email and conference calls. The "lung allograft standardized histological analysis - LASHA" template was created and structured as multiple-choice questions with number of fields to be filled in to allow for standardization of results and easy transfer into a future electronic spreadsheet. This template will help facilitate multicenter studies through a uniform protocol and correlations with new diagnostic modalities. After validation in large-scale studies, an optimized template could be included in routine clinical practice to enhance graft assessment and medical decision-making.

Sections du résumé

BACKGROUND
Routine monitoring of lung-transplanted patients is crucial for the identification of immunological and non-immunological complications. Determining the etiology of acute allograft dysfunction, particularly in alloimmune-mediated disorders, relies heavily on the lung biopsy with histopathologic analysis. Standardization of the pathologic diagnosis of rejection (e.g., cellular and antibody-mediated) is based on consensus statements and guidelines, indicating the importance of a multidisciplinary approach to achieve a definitive etiological diagnosis. In addition to these statements and guidelines, refinements and standardizations are feasible through systematic analysis morphological, immunophenotypic and molecular alterations observed in transbronchial biopsies. This study is to identify key morphologic features to be assessed, select consistent and reproducible terminology for each histological feature, and provide standardized definitions for pathological assessment and grading.
METHODS
A template was created by experts in lung transplantation including pathologists, pulmonologists, immunologists. An initial draft was circulated, followed by discussions and multiple revisions by email and conference calls.
RESULTS
The "lung allograft standardized histological analysis - LASHA" template was created and structured as multiple-choice questions with number of fields to be filled in to allow for standardization of results and easy transfer into a future electronic spreadsheet.
CONCLUSION
This template will help facilitate multicenter studies through a uniform protocol and correlations with new diagnostic modalities. After validation in large-scale studies, an optimized template could be included in routine clinical practice to enhance graft assessment and medical decision-making.

Identifiants

pubmed: 35931644
pii: S1053-2498(22)02019-8
doi: 10.1016/j.healun.2022.06.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1487-1500

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Fiorella Calabrese (F)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy. Electronic address: fiorella.calabrese@unipd.it.

Anja C Roden (AC)

Mayo Clinic College of Medicine, Laboratory Medicine and Pathology, Rochester, Minnesota.

Elizabeth Pavlisko (E)

Department of Pathology, Duke University, Durham, North Carolina.

Francesca Lunardi (F)

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.

Desley Neil (D)

Department of Histopathology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Benjamin Adam (B)

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.

David Hwang (D)

Latner Thoracic Surgery Research Laboratories, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Martin Goddard (M)

Department of Histopathology, Papworth Hospital NHS Trust, Cambridge, United Kingdom.

Gerald J Berry (GJ)

Department of Pathology, Stanford University, Stanford, California.

Marina Ivanovic (M)

Department of Pathology, University of Iowa, Iowa City, Iowa.

Jan von der Thüsen (JV)

Department of Pathology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.

Laure Gibault (L)

Department of Pathology, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris, France.

Chieh-Yu Lin (CY)

Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, Missouri.

Katharina Wassilew (K)

Department of Pathology, Rigshospitalet, Copenhagen, Denmark.

Carolyn Glass (C)

Department of Pathology, Duke University, Durham, North Carolina.

Glen Westall (G)

Lung Transplant Unit, Alfred Hospital, Melbourne, Australia.

Adriana Zeevi (A)

Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Deborah Jo Levine (DJ)

Department of Medicine, University of Texas Health Science Center San Antonio, Texas.

Antoine Roux (A)

Department of Pneumology, Hôpital Foch, Suresnes, France and Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH